2024. Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study. Dermatology Practical & Conceptual. 14, 4 (Oct. 2024), e2024250. DOI:https://doi.org/10.5826/dpc.1404a250.